Friday, June 2, 2017

BRIEF-GSK says ViiV Healthcare submits 2-drug HIV regimen application to EMA,U.S. FDA

* ‍Priority review voucher submitted in US with anticipated target action date of 6 months​

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)